Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenusCHIX:GNSL +4.44%72 EV-to-FCF is 35.34 as of Jul. 15, 2026, which is 64% below its 10-year median of 99.11. GuruFocus rates CHIX:GNSL with a GF Score™ of 72/100 and a GF Value™ of £20.75 (Fairly Valued). The stock has 5 warning signs investors should review. Among 336 Biotechnology companies, Genus ranks worse than 69.35% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genus's Enterprise Value is £1,618.5 Mil.
Genus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £45.8 Mil. Therefore, Genus's EV-to-FCF for today is 35.34.
The historical rank and industry rank for Genus's EV-to-FCF or its related term are showing as below:
CHIX:GNSl'
s EV-to-FCF Range Over the Past 10 Years
Min: -74.88 Med: 99.11 Max: 476.32
Current: 34.03
During the past 13 years, the highest EV-to-FCF of Genus was 476.32. The lowest was -74.88. And the median was 99.11.
CHIX:GNSl's EV-to-FCF is ranked worse than 69.35% of 336
companies
in the Biotechnology industry
Industry Median: 15.32
vs CHIX:GNSl: 34.03
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-15), Genus's stock price is £21.18.
Genus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.710. Therefore, Genus's PE Ratio (TTM) for today is 29.83.
Genus (CHIX:GNSl) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genus's share price for today is £21.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Genus EV-to-FCF Related Terms
Genus EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Genus's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:GNSL vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Genus's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genus EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genus's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Genus's EV-to-FCF falls into.
Genus's current Enterprise Value is £1,618.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £45.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genus (CHIX:GNSL) has a EV-to-FCF of 35.34 as of Jul. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genus and its competitors. This is 64% below median its historical median of 99.11. According to the industry distribution chart, Genus ranks #233 out of 336 companies in the Biotechnology industry, placing it in the top 69.3%.
Is Genus' EV-to-FCF too high?
Genus' current EV-to-FCF of 35.34 is 64% below median its 10-year median of 99.11. The Biotechnology industry median EV-to-FCF is 15.32. Genus' value of 35.34 is 130.7% above this industry median. Based on the distribution chart, Genus ranks #233 out of 336 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Genus has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genus ranks #233 out of 336 companies for EV-to-FCF. This places Genus in the lower half of its industry. The industry median EV-to-FCF is 15.32. Genus' value of 35.34 is 130.7% above this benchmark. While the company's 10-year median is 99.11 vs. the industry median of 15.32, Genus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.32, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genus's current EV-to-FCF of 35.34 is 130.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genus and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genus's current EV-to-FCF is 35.34, which is 64% below median its own 10-year median of 99.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (CHIX:GNSL) is currently considered Fairly Valued. The stock's GF Value™ is £20.75, compared to a current price of £21.18 — trading 2.1% above its estimated fair value. The current EV-to-FCF is 35.34, which is 64% below median its 10-year median of 99.11 and 130.7% above the Biotechnology industry median of 15.32. Genus' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Genus (CHIX:GNSL), the current EV-to-FCF is 35.34 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genus (CHIX:GNSL) Overvalued in 2026?
Based on GuruFocus' analysis, Genus stock appears to be overvalued.
The current stock price of £21.18 is trading 2.1% above its estimated GF Value™ of £20.75.
GuruFocus considers Genus to be Fairly Valued.
Key valuation signals for CHIX:GNSL:
EV-to-FCF: 35.34 (64% below median its 10-year median of 99.11)
GF Value™: £20.75 vs. price of £21.18 (2.1% above fair value)
Industry Position: 130.7% above the Biotechnology median (#233 of 336)
No single metric tells the full story. See the CHIX:GNSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
72GF Score
Get the complete analysis for CHIX:GNSL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:GNSL has been successfully added to your 
